Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 7, 2025
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
GlobeNewswire
·
April 7, 2025
TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia TNX-102 SL demonstrated statistically significant improvement in the primary endpoint of reduction in fibromyalgia …
ADMA Biologics Statement on Tariffs
GlobeNewswire
·
April 7, 2025
RAMSEY, N.J. and BOCA RATON, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics …
iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline
GlobeNewswire
·
April 7, 2025
Non-human primate pharmacokinetics data suggests IBIO-600, a potentially best-in-class long-acting anti-myostatin antibody, could have a human half-life as long as 130 days Additional interim in vivo data for a first-in-class Activin E antibody shows …
LG U+ Uses Denodo Platform to Build Modern, Integrated Data Management Infrastructure
GlobeNewswire
·
April 7, 2025
SEOUL, South Korea, April 07, 2025 (GLOBE NEWSWIRE) -- Denodo, a leader in data management, announced that it will provide its logical data management solution, the Denodo Platform, to LG U+, the mobile operator division of LG and the second-largest …
Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity
GlobeNewswire
·
April 7, 2025
-- Patients with acquired hypothalamic obesity on setmelanotide therapy (n=81) achieved mean BMI change of -16.5% compared with +3.3% for placebo (n=39) at 52 weeks (p<0.0001) -- -- -19.2% placebo-adjusted BMI reduction achieved in adult patients 18 years …
Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
April 7, 2025
Target enrollment achieved in RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, strengthening confidence in clinical timelines Enrollment underway in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for …
Telix Appoints Paul Schaffer as Chief Technology Officer
GlobeNewswire
·
April 7, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly created role of Chief Technology …
Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 7, 2025
HUNTSVILLE, AL, April 07, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Steve Ledger, Chief …
Jitterbit Earns 20 G2 Spring 2025 Badges for Leadership in Enterprise Automation, Integration and App Development
GlobeNewswire
·
April 7, 2025
ALAMEDA, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced its Harmony platform has been recognized as a leader by G2, the world's largest and most trusted …
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
GlobeNewswire
·
April 7, 2025
Participants with abnormal left ventricular mass index (LVMI) at baseline achieved 25% mean reduction in LVMI by 12 months or sooner Clinically meaningful improvements in majority of participants across cardiac biomarkers and functional measures All …
ExoraPad Presale Surges Past 70,000 XRP Raised, Set For DEX Launch and Launchpad Prototype Release in Q2 2025
GlobeNewswire
·
April 7, 2025
CORK, Ireland, April 07, 2025 (GLOBE NEWSWIRE) -- The excitement within the XRP community is hitting new highs as the ExoraPad presale explodes, crossing a remarkable milestone of 70,000 XRP raised. XRP enthusiasts and seasoned crypto investors, fresh from …
Trident Deepens Partnership with Democratic Republic of Congo for Digital Identity System
GlobeNewswire
·
April 7, 2025
SINGAPORE, April 07, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd (NASDAQ: TDTH) (“Trident” or the “Company”), a Singapore-based leader in digital transformation, technology optimization, and Web 3.0 activation, today announced progress in …
LIfT BioSciences Appoints Mark A. Exley as Chief Scientific Officer
GlobeNewswire
·
April 7, 2025
Mark brings 30 years of experience in R…
Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director
GlobeNewswire
·
April 7, 2025
Accomplished biotech investor with a track record of successful company-building and exits to lead Angelini Ventures’ international BioTech investment strategy Rome, Italy, 7 April 2025 – Angelini Ventures, the corporate venture firm of Angelini …
Sword Group: Investment in Cybersecurity and Artificial Intelligence
GlobeNewswire
·
April 7, 2025
The Group is making a strategic operation in Scotland with the acquisition of iDelta, a cybersecurity and observability data specialist. iDelta, is a micro-company based in Edinburgh and specialising in the delivery of bespoke data and AI solutions, …
Sword Group : Investissement dans la Cybersécurité et l’Intelligence Artificielle
GlobeNewswire
·
April 7, 2025
Le Groupe réalise une opération stratégique en Écosse avec l’acquisition d’iDelta, une entreprise experte en cybersécurité et en analyse des données permettant de mieux surveiller et piloter les systèmes informatiques. iDelta est une micro-entreprise basée …
Atos brings forward its first quarter 2025 revenue release to April 17, 2025 to synchronize with its liquidity reporting
GlobeNewswire
·
April 7, 2025
Press Release Atos brings forward its first quarter 2025 revenue release to April 17, 2025 to synchronize with its liquidity reporting Paris, France - April 7, 2025 – Atos SE announces that it brings forward its Q1 2025 revenue publication date to April 17 …
Atos avance la publication de son chiffre d'affaires du premier trimestre 2025 au 17 avril 2025, afin de l’aligner sur la date de publication de son rapport de liquidité
GlobeNewswire
·
April 7, 2025
Communiqué de presse Atos avance la publication de son chiffre d'affaires du premier trimestre 2025 au 17 avril 2025, afin de l’aligner sur la date de publication de son rapport de liquidité Paris, France – Le 7 avril 2025 – Atos SE annonce avancer la …